Pharmacodynamics in the Development of New Immunosuppressive Drugs, Therapeutic Drug Monitoring, vol.26, issue.6, pp.588-92, 2004. ,
DOI : 10.1097/00007691-200412000-00002
Is C2 Monitoring or Another Limited Sampling Strategy Superior to C0 Monitoring in Improving Clinical Outcomes in Adult Liver Transplant Recipients?, Therapeutic Drug Monitoring, vol.28, issue.5, pp.637-679, 2006. ,
DOI : 10.1097/01.ftd.0000243965.97964.ca
Expert Review in Transplantation (CONCERT) Group. Patient management by Neoral C(2) monitoring: an international consensus statement, Consensus on Neoral C Transplantation, vol.73, issue.29, pp.12-20, 2002. ,
The Clinical Benefits of Cyclosporine C2-Level Monitoring: A Systematic Review, Transplantation, vol.83, issue.12, pp.1525-1560, 2007. ,
DOI : 10.1097/01.tp.0000268306.41196.2c
Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference, Therapeutic Drug Monitoring, vol.31, issue.2, pp.139-52, 2009. ,
DOI : 10.1097/FTD.0b013e318198d092
Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation, New England Journal of Medicine, vol.357, issue.25, pp.2562-75, 2007. ,
DOI : 10.1056/NEJMoa067411
New Insights Into the Pharmacokinetics and Pharmacodynamics of the Calcineurin Inhibitors and Mycophenolic Acid: Possible Consequences for Therapeutic Drug Monitoring in Solid Organ Transplantation, Therapeutic Drug Monitoring, vol.31, issue.4, pp.416-451, 2009. ,
DOI : 10.1097/FTD.0b013e3181aa36cd
Inhibition of stimulated interleukin-2 production in whole blood: a practical measure of cyclosporine effect, Clin Chem, vol.45, issue.9, pp.1477-84, 1999. ,
DEFECTIVE INHIBITION OF PERIPHERAL CD8+ T CELL IL-2 PRODUCTION BY ANTI-CALCINEURIN DRUGS DURING ACUTE LIVER ALLOGRAFT REJECTION, Transplantation, vol.77, issue.12, pp.1815-1835, 2004. ,
DOI : 10.1097/01.TP.0000129914.75547.B3
Pharmacodynamic Monitoring of Calcineurin Phosphatase Activity in Transplant Patients Treated with Calcineurin Inhibitors, Drug Metabolism and Pharmacokinetics, vol.23, issue.3, pp.150-157, 2008. ,
DOI : 10.2133/dmpk.23.150
Distribution of calcineurin activity in blood cell fractions and impact of tacrolimus inhibition, Fundamental and Clinical Pharmacology, vol.25, issue.2, pp.137-181, 2006. ,
DOI : 10.1006/abio.1999.4422
Pharmacodynamic analysis of tacrolimus and cyclosporine in living-donor liver transplant patients, Clinical Pharmacology & Therapeutics, vol.78, issue.2, pp.168-81, 2005. ,
DOI : 10.1016/j.clpt.2005.04.008
Pretransplantation calcineurin activity: towards individualized therapy?, Liver International, vol.29, issue.10, pp.1454-1460, 2009. ,
DOI : 10.1111/j.1478-3231.2009.02146.x
Cytokines correlate with age in healthy volunteers, dialysis patients and kidney-transplant patients, Cytokine, vol.45, issue.3, pp.169-73, 2009. ,
DOI : 10.1016/j.cyto.2008.11.014
Pharmacodynamic Monitoring of Cyclosporine A in Renal Allograft Recipients Shows a Quantitative Relationship Between Immunosuppression and the Occurrence of Recurrent Infections and Malignancies, Transplantation, vol.82, issue.10, pp.1280-1285, 2006. ,
DOI : 10.1097/01.tp.0000243358.75863.57
Ciclosporin A Tapering Monitored by NFAT-Regulated Gene Expression: A New Concept of Individual Immunosuppression, Transplantation, vol.85, issue.1, pp.15-21, 2008. ,
DOI : 10.1097/01.tp.0000296824.58884.55